JJ
Jason Jay Dsilva
About Jason Jay Dsilva
Data last updated:
Jason Jay Dsilva is an Additional Director at Abbvie Therapeutics India Private Limited (since 2026). The company operates in Healthcare.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Abbvie Therapeutics India Private Limited U33201KA1994PTC023162 | Additional Director | 27 Jul 2026 | 1994 | Active |
Board colleagues of Jason Jay Dsilva
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ajay Gopikisan Piramal | 00028116 | Abbvie Therapeutics India Private Limited | Director |
| Anup Arvind Godbole | 09342708 | Abbvie Therapeutics India Private Limited | Director |
| Perumal Chinnaiah | Abbvie Therapeutics India Private Limited | Company Secretary | |
| Suresh Pattathil | 02748206 | Abbvie Therapeutics India Private Limited | Managing Director |
| Swati Ajay Piramal | 00067125 | Abbvie Therapeutics India Private Limited | Director |
| Vidhan Kedia | 06718606 | Abbvie Therapeutics India Private Limited | Director |
| Vivek Valsaraj | 06970246 | Abbvie Therapeutics India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jason Jay Dsilva
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jason Jay Dsilva
Jason Jay Dsilva currently holds 1 directorship: Abbvie Therapeutics India Private Limited (Additional Director, since 27 Jul 2026).
Jason Jay Dsilva was first appointed on 27 Jul 2026 as Additional Director at Abbvie Therapeutics India Private Limited.
The current boards of Jason Jay Dsilva's companies include Ajay Gopikisan Piramal (Abbvie Therapeutics India Private Limited), Anup Arvind Godbole (Abbvie Therapeutics India Private Limited), Perumal Chinnaiah (Abbvie Therapeutics India Private Limited), Suresh Pattathil (Abbvie Therapeutics India Private Limited), Swati Ajay Piramal (Abbvie Therapeutics India Private Limited), Vidhan Kedia (Abbvie Therapeutics India Private Limited), among others.